DYNE THERAPEUTICS INC. - COMMON STOCK
29.66
25-November-24 12:33:02
15 minutes delayed
Stocks
-0.03
-0.10%
Today's range
29.19 - 30.77
ISIN
N/A
Source
NASDAQ
-
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
12 Nov 2024 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
07 Nov 2024 16:15:00 By Nasdaq GlobeNewswire
-
09 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
23 Sep 2024 08:56:28 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Key Leadership Appointments
03 Sep 2024 06:31:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
29 Aug 2024 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
12 Aug 2024 17:10:00 By Nasdaq GlobeNewswire
-
24 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
-
13 Jun 2024 16:40:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
30 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
28 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
21 May 2024 20:39:57 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
20 May 2024 16:01:00 By Nasdaq GlobeNewswire
-
19 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
02 May 2024 16:10:00 By Nasdaq GlobeNewswire
-
27 Mar 2024 16:05:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
27 Mar 2024 08:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces CEO Transition
25 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >